Skip to main content
Positive Phase 2 Results Reported for TYK2 Inhibitor for Patients With Moderate to Severe Psoriasis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Positive Phase 2 Results Reported for TYK2 Inhibitor for Patients With Moderate to Severe Psoriasis
User login
Username
Password
Reset your password
Concept
Lead
score
Psoriasis
1
1
Lupus
0
0.67
Systemic Lupus Erythematosus
0
0.67
Receptors
0
0.45
Uveitis
0
0.39
Upper Respiratory Tract Infection
0
0.32
Otolaryngology
0
0.31
Cytokines
0
0.22
Interleukin
0
0.22
Nasopharyngitis
0
0.22
Plaque Psoriasis
0
0.22
Respiratory Tract
0
0.22
Tyrosine Kinase
0
0.22
Biologic Therapy
0
0.13
Headache
0
0.13
Specialty
Lead
score
Dermatology
1
1
Edit Tags